KYNTRA BIO, INC. KYNB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-11-14
KYNTRA BIO, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Wettig Thane | CEO | 2026-06-06 | Tax withheld | 198 | $6.71 |
| DeLucia David | Chief Financial Officer | 2026-06-06 | Tax withheld | 52 | $6.71 |
| Wettig Thane | CEO | 2026-05-14 | Buy | 2,800 | $7.09 |
| Wettig Thane | CEO | 2026-03-06 | Tax withheld | 277 | $6.84 |
| DeLucia David | Chief Financial Officer | 2026-03-06 | Tax withheld | 60 | $6.84 |
Source: SEC EDGAR filings · CIK 0000921299 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.